AstraZeneca Pharma India Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 3,057.89 million compared to INR 2,498.09 million a year ago. Revenue was INR 3,154.49 million compared to INR 2,570.05 million a year ago. Net income was INR 158.01 million compared to INR 293.04 million a year ago. Basic earnings per share from continuing operations was INR 6.32 compared to INR 11.72 a year ago. Diluted earnings per share from continuing operations was INR 6.32 compared to INR 11.72 a year ago.
For the nine months, sales was INR 9,123.27 million compared to INR 7,182.67 million a year ago. Revenue was INR 9,384.64 million compared to INR 7,363.72 million a year ago. Net income was INR 1,220.31 million compared to INR 820.21 million a year ago. Basic earnings per share from continuing operations was INR 48.81 compared to INR 32.81 a year ago. Diluted earnings per share from continuing operations was INR 48.81 compared to INR 32.81 a year ago.